Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis
Listen to this summary
The authors investigate the potential of positron emission tomography (PET) molecular imaging as a non-invasive diagnostic tool for immune checkpoint inhibitor (ICI)-associated myocarditis, a serious complication of cancer immunotherapy. They highlight the challenges of early diagnosis due to the disease's heterogeneous presentation and discuss recent advancements in imaging technologies that could enhance the detection and monitoring of this condition. The article aims to inform clinical practice and future research on the application of PET in managing ICI-associated myocarditis.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
View all →Jul 2, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities
Jun 30, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Normal Values for <sup>13</sup>N-Ammonia PET-derived Metrics in Heart Transplant Patients
Jun 9, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
PROGNOSTIC IMPACT OF MYOCARDIAL FLOW RESERVE ASSESSED BY CZT-SPECT
Jun 9, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Radiation dosimetry of <sup>15</sup>O-water based on dynamic large axial field of view PET
Jun 4, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study
More in Nuclear Medicine
View all →Jul 10, 2026 · Lancet (London, England)
Advancing the relevance of clinical trials for older patients
Jul 9, 2026 · Lancet (London, England)
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
Jul 9, 2026 · Lancet (London, England)
Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations
Jul 9, 2026 · Lancet (London, England)
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial
Jul 8, 2026 · The New England journal of medicine
Nutrition Therapy in Critically Ill Adults
Jul 8, 2026 · Lancet (London, England)
Systemic light chain and transthyretin amyloidosis-treatment advancements and future directions
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
